Literature DB >> 11181892

Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies.

M Matsumoto1, H Togashi, K Mori, K Ueno , S Ohashi, T Kojima, M Yoshioka.   

Abstract

The possible involvement of 5-HT(4) receptors in cognitive function was investigated with a view toward modulating the cholinergic neuronal system. For this purpose, behavioral, electrophysiological, and neurochemical studies were performed in rats. The behavioral study, using a passive avoidance test, demonstrated that the 5-HT(4) receptor agonist SC 53116 (10 microg/rat i.c.v.) had an ameliorative effect on the muscarinic receptor antagonist scopolamine-induced (1 mg/kg i.p.) impairment of learning. The electrophysiological study showed that SC 53116 (1 and 10 microg/rat i.c.v.) enhanced the population spike amplitude in the hippocampal CA1 field evoked by Schaffer collateral stimulation. SC 53116 (10 microg/rat i.c.v.) also augmented the tetanus-induced long-term potentiation (LTP). This augmented LTP was blocked not only by the selective 5-HT(4) receptor antagonist GR 113808 (20 microg/rat i.c.v.) but also by scopolamine (1 mg/kg i.p.). These findings suggest that the functional interaction between the serotonergic system mediated via 5-HT(4) receptors and the cholinergic system associated with cognitive processes exists in vivo. This possibility was further strengthened by neurochemical study using in vivo microdialysis; local administration of SC 53116 (10 and 100 microM) concentration-dependently enhanced the extracellular levels of acetylcholine (ACh) in the hippocampus. SC 53116-induced (10 microM) facilitation of ACh release was prevented by coperfusion of GR 113808 (10 microM). Taken together, the present findings obtained by these different approaches indicate the possibility that the 5-HT(4) receptors are involved in cognitive impairment induced by the cholinergic neuronal system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181892

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Effect of serotonergic receptor activation on the binding of [3H]quinuclidinyl benzylate by membrane muscarinic cholinoreceptors of the rat cerebral cortex.

Authors:  L A Nesterova; B N Manukhin
Journal:  Dokl Biol Sci       Date:  2004 May-Jun

2.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress.

Authors:  Machiko Matsumoto; Kaori Tachibana; Hiroko Togashi; Kazue Tahara; Taku Kojima; Taku Yamaguchi; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 4.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

5.  Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.

Authors:  Karine Madsen; Mette T Haahr; Lisbeth Marner; Sune H Keller; William F Baaré; Claus Svarer; Steen G Hasselbalch; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

6.  Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice.

Authors:  Luis Segu; Marie-José Lecomte; Mathieu Wolff; Julie Santamaria; René Hen; Aline Dumuis; Sylvie Berrard; Joël Bockaert; Marie-Christine Buhot; Valérie Compan
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

7.  Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.

Authors:  Thomas Freret; Véronique Lelong-Boulouard; Pierre Lecouflet; Katia Hamidouche; François Dauphin; Michel Boulouard
Journal:  Psychopharmacology (Berl)       Date:  2017-06-19       Impact factor: 4.530

8.  The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans.

Authors:  Mette Ewers Haahr; Patrick Fisher; Klaus Holst; Karine Madsen; Christian Gaden Jensen; Lisbeth Marner; Szabols Lehel; William Baaré; Gitte Knudsen; Steen Hasselbalch
Journal:  Hum Brain Mapp       Date:  2012-06-26       Impact factor: 5.038

Review 9.  The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.

Authors:  Mohammad Seyedabadi; Gohar Fakhfouri; Vahid Ramezani; Shahram Ejtemaei Mehr; Reza Rahimian
Journal:  Exp Brain Res       Date:  2014-01-16       Impact factor: 1.972

10.  Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex.

Authors:  Giorgi Batsikadze; Walter Paulus; Min-Fang Kuo; Michael A Nitsche
Journal:  Neuropsychopharmacology       Date:  2013-05-17       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.